| 查看: 642 | 回复: 0 | |||
mechen
|
[交流]
Molecular Determinants of Head and Neck Cancer); 2018 by Barbara Burtness
|
|
Molecular Determinants of Head and NSquamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that approximately 50,000 patients develop head and neck cancer annually in the United States, of whom approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is multimodal, often combining surgery or irradiation with chemotherapy; even successfully treated patients frequently experience durable and severe side effects. Improving cure rates and reducing chronic morbidity are urgent clinical needs for head and neck cancer. However, in contrast to cancer types such as breast or prostate that have been much studied and have well-defined biology, until recently, relatively few researchers investigated the molecular basis of HNC, making it difficult to design targeted treatments with better efficacy and less debilitating side effects. This volume will provide an overview of the factors contributing to disease pathogenesis, including the recognition of discrete molecular subtypes with distinct etiology, prognosis, and treatment response. This volume will familiarize the reader with the critical signaling pathways and oncogenic drivers for HNC. It will outline the differences between HPV-positive and HPV-negative disease, and how these differences affect treatment choice and outcome. The book will emphasize developments in the past five years, including the growing understanding of the genomic and epigenomic features of the disease based on analysis of next generation sequencing (NGS) data, and timely topics such as the analysis of HNC stem cell populations, non-coding mRNAs, and inflammatory response. It will address exciting new therapeutic approaches such as the use of immunotherapies to treat HNC patients. Overall, the book will provide the reader with current understanding of the biology and treatment of the disease, and describe timely questions that will guide future research aimed at controlling and curing this disease.eck Cancer); 2018, 2ndEdition by Barbara Burtness |
回复此楼» 本帖附件资源列表
-
欢迎监督和反馈：小木虫仅提供交流平台，不对该内容负责。
本内容由用户自主发布，如果其内容涉及到知识产权问题，其责任在于用户本人，如对版权有异议，请联系邮箱：xiaomuchong@tal.com - 附件 1 : Molecular_Determinants_of_Head_and_Neck_Cancer);_2018,_2ndEdition_by_Barbara_Burtness.rar
2018-08-12 17:17:16, 46.98 M
» 猜你喜欢
如何查询一个项目代号下所资助的项目名称
已经有3人回复
-
第一次sci投稿，大修后小修，下面是审稿人的意见，接收概率有多大?
已经有12人回复
-
泌尿系统论文润色/翻译怎么收费?
已经有98人回复
-
sci论文小修编辑没给审稿意见！
已经有13人回复
-
临床医学复试调剂 一志愿温州医科大学 321分
已经有0人回复
-
医学影像学调剂求助
已经有0人回复
-
同一参考文献引用多次，在参考文献处同一编号显示多次
已经有4人回复
-
中科院微电子所硕士寻找MEMS\超声\声镊或者其他方向2026博士机会
已经有0人回复
